Witnessing the stock’s movement on the chart, on Wednesday, Transmedics Group Inc (NASDAQ: TMDX) had a quiet start as it plunged -3.48% to $118.66, before settling in for the price of $122.94 at the close. Taking a more long-term approach, TMDX posted a 52-week range of $36.42-$177.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 95.07%. Meanwhile, its Annual Earning per share during the time was 8.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 263.38%. This publicly-traded company’s shares outstanding now amounts to $32.67 million, simultaneously with a float of $32.23 million. The organization now has a market capitalization sitting at $3.96 billion. At the time of writing, stock’s 50-day Moving Average stood at $150.16, while the 200-day Moving Average is $121.67.
Transmedics Group Inc (TMDX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Transmedics Group Inc’s current insider ownership accounts for 3.40%, in contrast to 103.10% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’24, this organization’s President & CEO sold 8,625 shares at the rate of 132.71, making the entire transaction reach 1,144,648 in total value, affecting insider ownership by 61,643. Preceding that transaction, on Oct 01 ’24, Company’s Chief Commercial Officer sold 2,958 for 148.24, making the whole transaction’s value amount to 438,491. This particular insider is now the holder of 20,843 in total.
Transmedics Group Inc (TMDX) Earnings and Revenue Records
Transmedics Group Inc’s EPS increase for this current 12-month fiscal period is 263.38% and is forecasted to reach 1.91 in the upcoming year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Let’s observe the current performance indicators for Transmedics Group Inc (TMDX). It’s Quick Ratio in the last reported quarter now stands at 8.48. The Stock has managed to achieve an average true range (ATR) of 6.39. Alongside those numbers, its PE Ratio stands at $3323.81, and its Beta score is 2.00. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.03.
In the same vein, TMDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.04, a figure that is expected to reach 0.29 in the next quarter, and analysts are predicting that it will be 1.91 at the market close of one year from today.
Technical Analysis of Transmedics Group Inc (TMDX)
Going through the that latest performance of [Transmedics Group Inc, TMDX]. Its last 5-days volume of 1.13 million indicated improvement to the volume of 0.84 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 11.02% While, its Average True Range was 5.90.
Raw Stochastic average of Transmedics Group Inc (TMDX) in the period of the previous 100 days is set at 3.42%, which indicates a major fall in contrast to 6.84% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 23.92% that was lower than 51.54% volatility it exhibited in the past 100-days period.
